This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $76,461.09, is for the provision of pharmaceutical and medical supplies to the TRICARE West program, which provides healthcare services to military members, retirees, and their families.
Cardinal Health, a major supplier of pharmaceuticals and medical products to the U.S. federal government, has a long-standing relationship with government procurement and has been registered to receive federal awards since 2001. The company has extensive experience in the Defense Logistics Agency's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. This delivery order contract does not have a set-aside designation, reflecting Cardinal Health's status as a large, for-profit corporation.
In addition to this specific delivery order, Cardinal Health holds a significant indefinite delivery contract (IDC) with the Department of Veterans Affairs (VA) for the supply of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. The company's subsidiary, The Harvard Drug Group, L.L.C., has also secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, demonstrating its ability to manage large-scale, multi-agency pharmaceutical supply agreements.